Displaying 655 - 664 of 735 results
-
Safety Signal: Changes to the labelling of Bicillin LA®Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidanceNew dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Opioid implementation packageThis package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Safe use of opioids measurement: frequently asked questionsFrequently asked questions about measurement for the safe use of opioids.
-
Safe use of opioids collaborative information for DHB hospitalsInformation document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
-
Safe Medication Management newsletters - 2010Newsletters from the SMM programme for the year 2010
-
Using REACH, a new modelling and forecasting tool, to understand the delay and backlog effects of COVID-19 on New Zealand's health system.McBride P, Hoang T, Hamblin R, Li Y, Shuker C, Wilson J, Bramley D
New Zealand Medical Journal -
Getting the story right: reflecting on an indigenous rubric to guide the interpretation of mortality dataCram F, Cannell H, Gulliver P
Journal of Interpersonal Violence -
Introduction of a standardised maternity early warning system: indicative data from a before-and-after study at a large pilot site before national rollout in Aotearoa New ZealandDrake M, Austin G, Dann L, Li Y, Shuker C, Psirides A
Anaesthesia